Duloxetine use in chronic painful conditions--individual patient data responder analysis. - Wikidata - awgldk - TriplyDB

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

http://www.wikidata.org/entity/Q34754874

about

Gabapentin for fibromyalgia pain in adults Transcutaneous Electrical Nerve Stimulation (TENS) for fibromyalgia in adults Physiotherapy for pain and disability in adults with complex regional pain syndrome (CRPS) types I and II Milnacipran for pain in fibromyalgia in adults Amitriptyline for neuropathic pain in adults Zonisamide for neuropathic pain in adults Milnacipran for neuropathic pain in adults Acupuncture for neuropathic pain in adults Nortriptyline for neuropathic pain in adults Morphine for neuropathic pain in adults Antipsychotics for fibromyalgia Pregabalin for pain in fibromyalgia in adults Buprenorphine for neuropathic pain in adults Antidepressant drugs for neuropathic pain - an overview of Cochrane reviews Hydromorphone for neuropathic pain in adults Buprenorphine for neuropathic pain in adults Fentanyl for neuropathic pain in adults Transcutaneous Electrical Nerve Stimulation (TENS) for chronic pain - an overview of Cochrane reviews Cannabinoids for fibromyalgia Amitriptyline for fibromyalgia in adults Oxycodone for neuropathic pain and fibromyalgia in adults Imipramine for neuropathic pain in adults Topical lidocaine for neuropathic pain in adults Zonisamide for neuropathic pain in adults Gabapentin for chronic neuropathic pain and fibromyalgia in adults Topical lidocaine for neuropathic pain in adults Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews Oxycodone for neuropathic pain in adults Cannabinoids for fibromyalgia Antipsychotics for fibromyalgia in adults Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults Hydromorphone for neuropathic pain in adults Cannabinoids for chronic neuropathic pain Methadone for neuropathic pain in adults Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: a network meta-analysis High correlation of VAS pain scores after 2 and 6 weeks of treatment with VAS pain scores at 12 weeks in randomised controlled trials in rheumatoid arthritis and osteoarthritis: meta-analysis and implications.Pregabalin for pain in fibromyalgia in adults.Fentanyl for neuropathic pain in adults.Topical capsaicin (high concentration) for chronic neuropathic pain in adults.Gabapentin for chronic neuropathic pain in adults.

P2860

Q24185818-5ABA4474-DBA1-4BEC-8FA9-20EDD772A652 Q24185947-A8202054-3E31-4158-AECE-C3BCA2494CFA Q24186109-FCE03D30-5FD1-4124-BEB9-EFC0CC9585D1 Q24186461-74864D6B-029E-47A5-BA82-7450A9ACB167 Q24186538-2AE67341-A01B-4A9C-AB3C-72965E4F4D48 Q24186542-626F1C8D-6784-4574-B076-97F928A018C7 Q24186555-C6393DC8-1EFA-4F59-92BA-2084EF4F9A7E Q24186657-C37E1AE5-BF28-4065-86AF-E84A8BCCB1CF Q24186696-0B406238-EBC0-4CC3-AAEF-0EBA2A854B70 Q24186741-3BBDAD03-74D9-48CF-A856-235F4968837C Q24186761-4C551FD8-7C64-4F52-A948-9B14A2D7D480 Q24186782-1001E09A-73EB-4D65-8CB0-88E5605400B8 Q24186924-71F80517-9AF7-408D-99BB-72C82F36C46F Q24186993-A5C448A7-EEC5-41DF-B6EC-80CD529346E6 Q24187550-1ADFF78A-F32D-49F5-A81C-1F9BB1125012 Q24187555-C4129C65-90A1-4DE4-BA3B-C48863F7CF74 Q24187562-639F79DC-CF40-4E36-88CD-20010721DE6C Q24187638-30B2CACC-6A28-48CB-9821-B564C6354C6E Q24188267-A0DD9A1B-BE85-415E-93EE-93AD1D295EFE Q24188299-76C6F2C3-0849-4FE0-9342-BE7B7FD75989 Q24193845-D3637D08-7AFE-455D-BBA5-FDF53892F3DC Q24194598-61049286-0A1B-4595-9995-453D02291978 Q24194814-6E9F307A-754B-4846-8666-83155506C286 Q24194963-930B5754-565F-4EC7-ABBA-83B6BBBF7D3A Q24194998-5B77FED3-310F-4A89-B9CF-9C26FAA6DC53 Q24200872-955F5CE5-1057-457B-AD37-B4C6E3E6D863 Q24202563-02C4BA3B-0FED-4688-9925-5032E538DFBE Q26470985-47423181-A2CD-4C50-BC9E-ED5BFAA0A33D Q26471052-91054952-7780-43D8-899C-E10A92AB0787 Q26471557-D2A0D45F-A9DA-44D6-B5BD-8A53EB4D0299 Q26471756-A1E464DB-EE3C-4EB0-8BE7-EC54B0F6BB51 Q26471921-EC52D2FC-8109-47B1-B825-496AC12BCA3E Q26472068-0114BFEF-F9E6-4658-9FC2-3196DC00B996 Q29994484-A63F808A-9060-42AC-AD89-DC0B1CE3E8A4 Q34471991-ACA80A3E-0238-42FC-85C5-C99047C763A6 Q34520597-2B62AE32-63D3-46CA-8E23-E5A57ED17C97 Q34541472-2861C4AB-7D9D-48CF-87C0-E726B70DC34E Q34542356-17C51106-71A8-4AB1-AA66-3E9441C66F2F Q34549233-64306944-FAB3-4692-ACF4-E4CD309EE726 Q34557703-F75B5B71-93C0-4415-B915-85F3015C741B

P2860

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

http://www.wikidata.org/entity/Q34754874

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@ast

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@en

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@nl

type

label

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@ast

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@en

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@nl

prefLabel

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@ast

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@en

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@nl

P1433

Q34754874-5C76FD65-3D7B-4A2D-9CC1-EF18CD9EE9FC

P1476

Q34754874-936ABD4F-410B-4EDF-9DC2-CC2E8FA5FC87

P2093

Q34754874-2D44C541-0BE7-44D9-8399-D984989270B5

Q34754874-3068CEC0-D44D-4E50-BA79-89745485C5B9

Q34754874-330B9B50-76DD-4782-A086-E6213C9F4E99

Q34754874-82A1386C-00E8-40B2-925C-9EBD77CB2B3F

P2860

Q34754874-06A7DAC3-E84D-4DE2-97A5-3BB70A67145B

Q34754874-0BF90D4D-6295-480F-9C36-84C19FB21B1D

Q34754874-10140377-DE2B-4232-99F6-9818E414102B

Q34754874-149D81DE-A784-4D4D-A00F-3F95A16F6AEC

Q34754874-1B5FFDCA-EA7B-48CC-9586-EFF334C9F4A9

Q34754874-1BE61729-4791-4974-8E05-D4C869013464

Q34754874-1EAFDD8A-9EAE-4B3F-BDBA-6F392287EB72

Q34754874-20AED9A7-35BE-4D56-97D0-D134D409D995

Q34754874-23E91B1F-6B2A-4D13-93A5-D483387C4CF2

Q34754874-2B92F27C-9399-4F0E-B13C-F67E64B8AC78

P304

Q34754874-A4318FA8-CDCE-4475-BF85-F61E3E4D85E8

P31

Q34754874-EBAF804D-C898-4DB2-84FB-6033116DC8DD

P356

Q34754874-C4B926DE-31D3-402B-AEC0-90BC4FAC6BAE

P433

Q34754874-9C65E232-ACD5-4AFB-801B-14F5B3662EC4

P478

Q34754874-5CDA8267-D052-4595-9D00-239A75097FDE

P577

Q34754874-F76AC891-C9F2-41A1-A78A-4BF18802BDAA

P5875

Q34754874-EBC56ECD-E0FC-4837-98EC-E9BBF66D99AB

P698

Q34754874-ADC539AA-FEA3-4061-BD7B-879DD4286BD7

P921

Q34754874-27D8FE77-6503-4BEB-8B8B-1297AE72CA05

P932

Q34754874-B20FA384-B4AD-4CFC-AFC5-24FF75225D24

P356

J.1532-2149.2013.00341.X

P1433

European Journal of Pain

P1476

Duloxetine use in chronic painful conditions--individual patient data responder analysis.

@en

P2093

N Cai

http://www.w3.org/2001/XMLSchema#string

R A Moore

http://www.w3.org/2001/XMLSchema#string

T R Tölle

http://www.w3.org/2001/XMLSchema#string

V Skljarevski

http://www.w3.org/2001/XMLSchema#string

P2860

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

Amitriptyline for neuropathic pain and fibromyalgia in adults

Pregabalin for acute and chronic pain in adults

Duloxetine for treating painful neuropathy or chronic pain

Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response

Recommendations for the pharmacological management of neuropathic pain: an overview and literature update

Impact of covert duplicate publication on meta-analysis: a case study

Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study

The number needed to treat: a clinically useful measure of treatment effect

Pregabalin in fibromyalgia--responder analysis from individual patient data

P304

67-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/J.1532-2149.2013.00341.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237017662

http://www.w3.org/2001/XMLSchema#string

P698

23733529

http://www.w3.org/2001/XMLSchema#string

P921

P932

4302330

http://www.w3.org/2001/XMLSchema#string